The Himalaya Drug Companys Liv.52, a phyto-pharmaceutical formulation for the management of liver disorders, will feature in the Limca Book of Records: Business Edition (2013) as the highest selling herbal drug in India, both in terms of units and rupee value.
Since its launch in 1955, Liv.52 has become the countrys top hepatoprotective. Currently a Rs. 150 crore brand, it is the only herbal drug to feature in the top ten of the bestselling drugs in India, according a report by Indian Pharmaceutical Market (IPM), said Philipe Haydon, CEOâPharmaceutical Division, The Himalaya Drug Company. Talking about the promotional route for Liv.52, Haydon elaborated, Like all our pharmaceutical products, Liv.52 is also promoted ethically through doctor prescription. Currently, over 400,000 (4 lakh) doctors across the globe prescribe Himalayas products,
Over the years, Himalaya has expanded the Liv.52 brand and developed medicines for other liver ailments. A double strength formulation, Liv.52 DS, recommended in drug-induced hepatitis and early cirrhotic conditions was introduced in 1996.
On receiving the certificate from the Limca Book of Records, Haydon added Liv.52 has been our flagship brand since 1955 and we are thrilled with this honor. The success of Liv.52 tells us that today herbal medicine is gaining global acceptance and when combined with allopathic therapies, it can vastly improve patients quality of life.
Limca Book of Records, launched in 1990, emphasizes on unique achievements of Indians and Indian companies within the country and abroad. Records are divided into multiple categories, which include music, entertainment, human story, radio and cinema.